Case Study: Georgiamune

Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.

Background

Georgiamune was founded in 2023 with a mission of reprogramming immune signaling pathways to redirect the immune system to fight diseases. Since its founding, Georgiamune has designed unique approaches to re-establish immune balance and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. The company’s lead program, GIM-122, is a first-in-class, dual-functioning monoclonal antibody, and is designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases.

Georgiamune hired Karbo Communications to increase advocacy of Georgiamune’s technology and competitive differentiators to attract first-in-class partners and employees, and expand thought leadership and authority for the Georgiamune team. The company looked to Karbo Communications to drive conversations with key media around innovation in immunology and autoimmune therapies.

Objectives

Lay the groundwork for the next funding through thought leadership and bold narrative development
Attract first-in-class partners and employees through strategic media and award efforts
Further establish Dr. Khleif, CEO and founder of Georgiamune, as a thought leader and pursue strategic media and award opportunities

Execution

Karbo Communications partnered with Georgiamune to develop and execute a comprehensive communications strategy to increase brand awareness, attract top-flight talent, and expand thought leadership and industry influence. From the beginning of the partnership, Karbo Communications strategically positioned Georgiamune as a fast-growing science and discovery company developing novel drugs to cure cancer and autoimmune diseases.

To further position Dr. Khleif as an expert source for autoimmune disease and immunotherapy and educate the market on Georgiamune’s strengths, Karbo Communications initiated an introductory campaign and secured interviews with top business journalists from Axios, Wall Street Journal, Forbes, and Business Insider.

Additionally, Karbo Communications pursued high-impact award opportunities poised to position Dr. Khleif as an innovative CEO and founder, and hit the ground running developing applications for the Ernst & Young Entrepreneur of the Year Awards, BioBuzz Breakthrough of the Year, and Fast Company’s Most Innovative Workplaces.

Results

Almost immediately as partners, Karbo Communications identified high-impact awards for Georgiamune, and opportunities to award Dr. Khleif for his leadership and innovativeness, including the Ernst & Young Entrepreneur of the Year Awards in which Georgiamune moved on to be a finalist out of thousands of applicants.

Within the first two months of working together, Karbo Communications secured a feature story in Business Insider highlighting the company’s business ambitions and recent funding round. The team also launched a social media program on LinkedIn to bolster talent acquisition, increasing engagement by 88% and securing more than 14,000 impressions.

A sampling of media that have featured Georgiamune:

Learn more about how Karbo can increase market awareness for your company.

Get in touch

Results realized.

Discover how our aggressive, data-driven approach consistently drives business outcomes for organizations like yours.